|
Type 2 diabetes
Citations 241-250 of 450 total displayed.
|
Past content
(since Jan 2001):
|
- Articles
Randomized Clinical Trial of Abciximab in Diabetic Patients Undergoing Elective Percutaneous Coronary Interventions After Treatment With a High Loading Dose of Clopidogrel
- Julinda Mehilli, Adnan Kastrati, Helmut Schühlen, Alban Dibra, Franz Dotzer, Nicolas von Beckerath, Hildegard Bollwein, Jürgen Pache, Josef Dirschinger, Peter P. Berger, Albert Schömig for the Intracoronary Stenting and Antithrombotic Regimen: Is Abciximab a Superior Way to Eliminate Elevated Thrombotic Risk in Diabetics (ISAR-SWEET) Study Investigators
Circulation published November 7, 2004, doi:10.1161/01.CIR.0000148956.93631.4D
[Abstract]
- Coronary Heart Disease
Subclinical Coronary Atherosclerosis in Asymptomatic Filipino and White Women
- Maria Rosario G. Araneta and Elizabeth Barrett-Connor
Circulation 2004;110:2817-2823; published online before print as doi:10.1161/01.CIR.0000146377.15057.CC
[Abstract]
[Full text]
- Articles
Low-Density Lipoprotein Triglycerides Associated With Low-Grade Systemic Inflammation, Adhesion Molecules, and Angiographic Coronary Artery Disease. The Ludwigshafen Risk and Cardiovascular Health Study
- Winfried März, Hubert Scharnagl, Karl Winkler, Andreas Tiran, Markus Nauck, Bernhard O. Boehm, and Bernhard R. Winkelmann
Circulation published October 25, 2004, doi:10.1161/01.CIR.0000146898.06923.80
[Abstract]
- Articles
Subclinical Coronary Atherosclerosis in Asymptomatic Filipino and White Women
- Maria Rosario G. Araneta and Elizabeth Barrett-Connor
Circulation published October 25, 2004, doi:10.1161/01.CIR.0000146377.15057.CC
[Abstract]
- Basic Science for Clinicians
Insulin-Like Growth Factor-1 as a Vascular Protective Factor
- Elena Conti, Cinzia Carrozza, Ettore Capoluongo, Massimo Volpe, Filippo Crea, Cecilia Zuppi, and Felicita Andreotti
Circulation 2004;110:2260-2265, doi:10.1161/01.CIR.0000144309.87183.FB
[Full text]
- Basic Science for Clinicians
Genetic Basis of Atherosclerosis: Part II: Clinical Implications
- Aldons J. Lusis, Alan M. Fogelman, and Gregg C. Fonarow
Circulation 2004;110:2066-2071, doi:10.1161/01.CIR.0000143098.98869.F8
[Full text]
- Basic Science for Clinicians
Genetic Basis of Atherosclerosis: Part I: New Genes and Pathways
- Aldons J. Lusis, Alan M. Fogelman, and Gregg C. Fonarow
Circulation 2004;110:1868-1873, doi:10.1161/01.CIR.0000143041.58692.CC
[Full text]
- Correspondence
One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS Stent in Patients With Diabetes Mellitus • Response
- Aloke V. Finn, Herman K. Gold, Gregg W. Stone, Stephen G. Ellis, David A. Cox, James Hermiller, Charles O’Shaughnessy, James Tift Mann, Mark Turco, Ronald Caputo, Patrick Bergin, Joel Greenberg, Jeffrey J. Popma, and Mary E. Russell
Circulation 2004;110:e318-319e, doi:10.1161/01.CIR.0000142207.05425.76
[Full text]
- Coronary Heart Disease
Circulating Mononuclear Cells in the Obese Are in a Proinflammatory State
- Husam Ghanim, Ahmad Aljada, Deborah Hofmeyer, Tufail Syed, Priya Mohanty, and Paresh Dandona
Circulation 2004;110:1564-1571; published online before print as doi:10.1161/01.CIR.0000142055.53122.FA
[Abstract]
[Full text]
- Coronary Heart Disease
Newly Diagnosed and Previously Known Diabetes Mellitus and 1-Year Outcomes of Acute Myocardial Infarction: The Valsartan in Acute Myocardial Infarction (VALIANT) Trial
- David Aguilar, Scott D. Solomon, Lars Køber, Jean-Lucien Rouleau, Hicham Skali, John J.V. McMurray, Gary S. Francis, Marc Henis, Christopher M. O’Connor, Rafael Diaz, Yuri N. Belenkov, Sergei Varshavsky, Jeffrey D. Leimberger, Eric J. Velazquez, Robert M. Califf, and Marc A. Pfeffer
Circulation 2004;110:1572-1578; published online before print as doi:10.1161/01.CIR.0000142047.28024.F2
[Abstract]
[Full text]
|
|
